Bitter Taste Receptors and Endocrine Disruptors: Cellular and Molecular Insights from an In Vitro Model of Human Granulosa Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
08 Dec 2022
Historique:
received: 09 11 2022
revised: 01 12 2022
accepted: 06 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Endocrine disrupting chemicals (EDCs) are compounds that interfere with the synthesis, transport and binding action of hormones responsible for reproduction and homeostasis. Some EDCs compounds are activators of Taste bitter Receptors, a subclass of taste receptors expressed in many extraoral locations, including sperm and follicular somatic cells. This makes TAS2Rs attractive molecules to study and investigate to shed light on the effect of EDCs on female reproduction and fertility. This study aims to assess the effect of selected EDCs [namely Biochanin A (BCA), caffeine, Daidzein, Genistein and Isoflavone] on hGL5, an immortalized cell line exhibiting characteristics coherent with primary follicular granulosa cells. After demonstrating that this model expresses all the TAS2Rs (TAS2R3, TAS2R4, TAS2R14, TAS2R19, TAS2R43) specifically expressed by the primary human granulosa cells, we demonstrated that BCA and caffeine significantly affect mitochondrial footprint and intracellular lipid content, indicating their contribution in steroidogenesis. Our results showed that bitter taste receptors may be involved in steroidogenesis, thus suggesting an appealing mechanism by which these compounds affect the female reproductive system.

Identifiants

pubmed: 36555195
pii: ijms232415540
doi: 10.3390/ijms232415540
pmc: PMC9779643
pii:
doi:

Substances chimiques

Endocrine Disruptors 0
Receptors, G-Protein-Coupled 0
Caffeine 3G6A5W338E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : University of Siena
ID : Internal funds

Références

Int J Mol Sci. 2015 Apr 30;16(5):9831-49
pubmed: 25941928
Chem Senses. 2015 Nov;40(9):627-39
pubmed: 26377344
Fertil Steril. 2008 Oct;90(4):911-40
pubmed: 18929049
Reprod Fertil Dev. 2015 Feb 10;:
pubmed: 25664578
Sci Rep. 2017 Apr 11;7:46166
pubmed: 28397820
J Clin Endocrinol Metab. 1994 Mar;78(3):705-10
pubmed: 8126145
Int J Mol Sci. 2020 May 19;21(10):
pubmed: 32438750
Cells. 2021 Jul 22;10(8):
pubmed: 34440620
J Clin Med. 2020 Jan 18;9(1):
pubmed: 31963712
Front Physiol. 2022 Jan 28;12:807685
pubmed: 35153815
Endocrinology. 2019 Apr 1;160(4):729-743
pubmed: 30689811
JAMA. 2021 Jul 06;326(1):65-76
pubmed: 34228062
Biol Reprod. 2010 Aug 1;83(2):286-95
pubmed: 20357270
Horm Behav. 2002 Mar;41(2):220-8
pubmed: 11855907
Int J Endocrinol. 2020 Jul 21;2020:9251980
pubmed: 32774366
PLoS One. 2012;7(9):e45829
pubmed: 23029265
Cells. 2022 Apr 23;11(9):
pubmed: 35563737
Int J Mol Sci. 2017 Apr 28;18(5):
pubmed: 28452938
Evid Based Complement Alternat Med. 2017;2017:5435831
pubmed: 28642799
Hum Reprod Update. 2008 Mar-Apr;14(2):159-77
pubmed: 18175787
J Cell Sci. 2009 Aug 15;122(Pt 16):2787-91
pubmed: 19657014
Environ Res. 2021 Mar;194:110694
pubmed: 33385395
J Vet Med Sci. 2004 Nov;66(11):1311-4
pubmed: 15585941
Curr Opin Obstet Gynecol. 2017 Aug;29(4):202-211
pubmed: 28557831
Chem Senses. 2010 Feb;35(2):157-70
pubmed: 20022913
J Urol. 2011 Dec;186(6):2455-62
pubmed: 22019168
Toxicology. 2013 May 10;307:35-41
pubmed: 23380243
Mol Cell Endocrinol. 2016 Dec 5;437:11-21
pubmed: 27502035
J Agric Food Chem. 2011 Nov 9;59(21):11764-71
pubmed: 21942422
Reprod Toxicol. 2021 Jan;99:96-108
pubmed: 33285269
Reprod Biomed Online. 2011 Aug;23(2):196-203
pubmed: 21680247
Acta Histochem. 2017 Apr;119(3):315-326
pubmed: 28314612
Nat Med. 2010 Nov;16(11):1299-304
pubmed: 20972434
Theriogenology. 2013 Oct 15;80(7):821-8
pubmed: 23953692
Environ Health Perspect. 2002 Aug;110(8):743-8
pubmed: 12153753
Endocrinology. 1998 Oct;139(10):4252-63
pubmed: 9751507
Cells. 2021 Nov 11;10(11):
pubmed: 34831350
Endocr Rev. 2009 Jun;30(4):293-342
pubmed: 19502515
Int J Mol Sci. 2020 Jul 21;21(14):
pubmed: 32708215
Reprod Sci. 2018 Apr;25(4):579-586
pubmed: 28683601
Reprod Sci. 2014 Oct;21(10):1249-55
pubmed: 24520083
Int J Mol Sci. 2019 Feb 22;20(4):
pubmed: 30813355
Ann Saudi Med. 2013 May-Jun;33(3):217-22
pubmed: 23793421
J Steroid Biochem Mol Biol. 1999 Dec 31;71(5-6):191-202
pubmed: 10704908
Biosci Rep. 2019 Dec 20;39(12):
pubmed: 31808518
Toxicol Sci. 2019 May 1;169(1):5-13
pubmed: 30690568
J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2007 Jan;193(1):21-34
pubmed: 17021831
Mol Cell Endocrinol. 2004 Dec 30;228(1-2):67-78
pubmed: 15541573

Auteurs

Francesca Paola Luongo (FP)

Department of Molecular and Developmental Medicine, Siena University, 53100 Siena, Italy.

Sofia Passaponti (S)

Department of Life Sciences, University of Siena, 53100 Siena, Italy.

Alesandro Haxhiu (A)

Department of Molecular and Developmental Medicine, Siena University, 53100 Siena, Italy.

Maryam Raeispour (M)

Department of Molecular and Developmental Medicine, Siena University, 53100 Siena, Italy.

Giuseppe Belmonte (G)

Department of Molecular and Developmental Medicine, Siena University, 53100 Siena, Italy.

Laura Governini (L)

Department of Molecular and Developmental Medicine, Siena University, 53100 Siena, Italy.

Livio Casarini (L)

Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41126 Modena, Italy.

Paola Piomboni (P)

Department of Molecular and Developmental Medicine, Siena University, 53100 Siena, Italy.

Alice Luddi (A)

Department of Molecular and Developmental Medicine, Siena University, 53100 Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH